Boryung Pharmaceutical Reports 3Q Operating Profit of 18.5 Billion KRW, Up 44% YoY
[Asia Economy Reporter Ji Yeon-jin] Boryung Pharmaceutical announced on the 27th that its sales revenue for the third quarter of this year reached 158.2 billion KRW, an 8.86% increase compared to the same period last year.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military Spokesperson: "Ceasefire Was an Opportunity to Strengthen Forces... Ready to Respond to War"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
During this period, operating profit increased by 44.06% to 18.5 billion KRW, while net profit decreased by 42.07% to 4.6 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
